Frequency Exchange Corp. announced that its wholly owned operating subsidiary FREmedica Technologies Inc. has agreed to the terms with the Frequency Warehouse Inc. The Terms sets out the terms and conditions pursuant to which FREmedica will expand its current frequency program to include a suite of new wellness and performance enhancement frequencies, new wearable hardware and a subscription model which will be the launch of FREmedica's new recurring revenue program. FREmedica intends to develop and deliver frequencies to people via annual memberships allowing them to access a variety of new wellness and performance frequencies to enhance body function.

FREmedica intends to offer an increasing variety of frequencies to members as the membership grows. The frequencies will be built by the Warehouse and exclusively supplied to FREmedica for use exclusively through the Membership program. The Management Team of the Company believes that people will benefit from the Membership when they access and use frequencies designed to support their personal well-being.

Currently, FREmedica is focused on exclusively selling the Wave 1 frequency emitter and Lyme-related frequencies to those who have been diagnosed with Lyme Disease. FREmedica is taking what it has learned in overcoming the impact of Lyme disease and is now applying this successful approach to general wellness and personal performance. Under the Terms, to which FREmedica will expand its current frequency program to include a suite of new wellness and performance enhancement frequencies, new wearable hardware and a subscription model which will be the launch of FREmedica's new recurring revenue program and in consideration of: i) the payment of a 10% gross revenue royalty pertaining to the sale of the Membership and any fees collected for additional frequency services being offered through the Membership, to the Warehouse; and ii) to the payment of a one-time fee of CAD 150,000 for R&D costs for the exclusive access to frequencies along with the wearable technology to deliver the frequencies which in combination will be used by FREmedica to launch its Membership Program and activate its recurring revenue model.